Lauran Neergaard

Stay informed with Lauran Neergaard’s coverage and analysis for Fortune.

Page 3 of 5

  • Ampoules containing the Corona vaccine Nuvaxovid from the manufacturer NovavaxHealth

    CDC endorses Novavax COVID shot for adults, adding to the number of vaccine options

    By Lauran Neergaard and The Associated Press
  • Pig-human heart transplantsHealth

    Pig-to-human organ transplants inch closer to reality with testing for the deceased

    By Lauran Neergaard and The Associated Press
  • Novavax has developed its own Covid-19 vaccine.Health

    Novavax COVID shot is approved by FDA advisers, raising possibility of a fourth U.S. vaccine option

    By Lauran Neergaard and The Associated Press
  • Novovax COVID-19 vaccineHealth

    Novavax’s COVID-19 vaccine could finally be approved in the U.S. this month

    By Lauran Neergaard and The Associated Press
  • CHIANG MAI, THAILAND &#8211; 2022/03/07: A healthcare worker administers the Pfizer-BioNTech (Comirnaty) Covid-19 booster jab to a boy during the vaccination campaign.<br /> Thailand is vaccinating children from the age of 5-11years against covid-19 with Pfizer vaccine to contain the surge of covid-19 at Baan Sankamphaeng School. (Photo by Pongmanat Tasiri/SOPA Images/LightRocket via Getty Images)Health

    CDC urges Pfizer booster for children ages 5 to 11

    By Lauran Neergaard and The Associated Press
  • Boy receives COVID-19 vaccineHealth

    FDA authorizes Pfizer booster for children ages 5 to 11

    By Lauran Neergaard and The Associated Press
  • A nurse prepares a pediatric dose of the Pfizer-BioNTech Covid-19 vaccine.Health

    FDA restricts Johnson & Johnson’s COVID-19 vaccine to people 18 and older due to blood clot risk

    By Matthew Perrone, Lauran Neergaard, and others
  • COVID-19 vaccine for kidsHealth

    Moderna asks the FDA to authorize low doses of its COVID vaccine for kids under 6

    By Lauran Neergaard and The Associated Press
  • FILE &#8211; A health worker administers a dose of COVID-19 vaccine during a vaccination clinic in Reading, Pa. COVID-19 vaccinations are at a critical juncture as companies test whether new approaches like combination shots or nasal drops can keep up with a mutating coronavirus — even though it’s not clear if any change is needed. (AP Photo/Matt Rourke, File)Health

    COVID shots still work, but researchers hunt new improvements

    By Lauran Neergaard and The Associated Press
  • Man receives Pfizer COVID vaccineHealth

    FDA approves additional Pfizer and Moderna COVID boosters for adults 50 and older

    By Lauran Neergaard, Matthew Perrone, and others
  • Child gets vaccinated against COVIDHealth

    Moderna’s trial results show its COVID-19 vaccine work for kids under 6

    By Lauran Neergaard and The Associated Press
  • Pig Heart TransplantHealth

    Man who received a heart transplant from a pig dies after two months of unknown causes

    By Lauran Neergaard, Carla K. Johnson, and others
  • CDC panel approves booster shots for young teensHealth

    CDC panel approves Pfizer boosters for younger teens

    By Lauran Neergaard, Mike Stobbe, and others
  • Pfizer booster eligibilityHealth

    FDA clears Pfizer boosters for 12-to-15 year-olds

    By Lauran Neergaard and The Associated Press
  • FILE &#8211; In this March 26, 2021, file photo a member of the Philadelphia Fire Department prepares a dose of the Johnson &amp; Johnson COVID-19 vaccine at a vaccination site setup in Philadelphia. U.S. health officials say Johnson &amp; Johnson’s COVID-19 vaccine may pose a “small possible risk” of a potentially dangerous neurological reaction. The Centers for Disease Control and Prevention said Monday, July 12 that it has received reports of 100 people who got the shot developing an immune system disorder that can causes muscle weakness and occasionally paralysis. (AP Photo/Matt Rourke, File)Health

    CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson

    By Lauran Neergaard, Mike Stobbe, and others